- Home
- CCSI vs ETON Comparison
CCSI vs ETON Comparison
Compare CCSI & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCSI
- ETON
- Stock Information
- Founded
- CCSI 2021
- ETON 2017
- Country
- CCSI United States
- ETON United States
- Employees
- CCSI N/A
- ETON N/A
- Industry
- CCSI Retail: Computer Software & Peripheral Equipment
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- CCSI Technology
- ETON Health Care
- Exchange
- CCSI Nasdaq
- ETON Nasdaq
- Market Cap
- CCSI 475.1M
- ETON 428.5M
- IPO Year
- CCSI N/A
- ETON 2018
- Fundamental
- Price
- CCSI $23.20
- ETON $17.07
- Analyst Decision
- CCSI Hold
- ETON Strong Buy
- Analyst Count
- CCSI 5
- ETON 3
- Target Price
- CCSI $27.20
- ETON $27.67
- AVG Volume (30 Days)
- CCSI 146.8K
- ETON 231.3K
- Earning Date
- CCSI 05-07-2025
- ETON 05-13-2025
- Dividend Yield
- CCSI N/A
- ETON N/A
- EPS Growth
- CCSI N/A
- ETON N/A
- EPS
- CCSI 4.32
- ETON N/A
- Revenue
- CCSI $349,374,000.00
- ETON $39,011,000.00
- Revenue This Year
- CCSI $1.26
- ETON $92.33
- Revenue Next Year
- CCSI $0.88
- ETON $54.19
- P/E Ratio
- CCSI $5.43
- ETON N/A
- Revenue Growth
- CCSI N/A
- ETON 23.29
- 52 Week Low
- CCSI $12.67
- ETON $3.18
- 52 Week High
- CCSI $32.10
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- CCSI 65.46
- ETON 62.16
- Support Level
- CCSI $19.24
- ETON $16.43
- Resistance Level
- CCSI $24.03
- ETON $17.74
- Average True Range (ATR)
- CCSI 0.98
- ETON 0.92
- MACD
- CCSI 0.55
- ETON 0.06
- Stochastic Oscillator
- CCSI 83.74
- ETON 73.09
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.